Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:7502-7502
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Rubenstein James L.¹,Fraser Eleanor¹,Formaker Paul¹,Lee James Chi-Chiang¹,Chen Nianhang²,Kock Mallory³,Cheung Wesley¹,Wang Xiaomin⁴,Munster Pamela N.¹,Damato Bertil¹

Affiliation:

1. University of California, San Francisco, San Francisco, CA;

2. Celgene Corporation, Summit, NJ;

3. Celgene, Summit, NJ;

4. Celgene, Summit, CA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.7502

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in therapeutic strategies for primary CNS B-cell lymphomas;Expert Review of Hematology;2022-04-03

2. Novel Agents in Primary Central Nervous System Lymphoma;Novel Therapeutics for Rare Lymphomas;2019-10-24

3. Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report;Journal of Clinical Oncology;2019-03-10

4. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma;British Journal of Haematology;2018-11-23

5. Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma;Blood;2018-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP